Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Maria Anna Siciliano"'
Autor:
Maria Teresa Di Martino, Mariamena Arbitrio, Daniele Caracciolo, Alessia Cordua, Onofrio Cuomo, Katia Grillone, Caterina Riillo, Giulio Caridà, Francesca Scionti, Caterina Labanca, Caterina Romeo, Maria Anna Siciliano, Maria D'Apolito, Cristina Napoli, Martina Montesano, Valentina Farenza, Valentina Uppolo, Michele Tafuni, Federica Falcone, Giuseppe D'Aquino, Natale Daniele Calandruccio, Francesco Luciano, Licia Pensabene, Pierosandro Tagliaferri, Pierfrancesco Tassone
Publikováno v:
Molecular Therapy: Nucleic Acids, Vol 27, Iss , Pp 1191-1224 (2022)
Among deregulated microRNAs (miRs) in human malignancies, miR-221 has been widely investigated for its oncogenic role and as a promising biomarker. Moreover, recent evidence suggests miR-221 as a fine-tuner of chronic liver injury and inflammation-re
Externí odkaz:
https://doaj.org/article/3c736b7269e24e3894170eed8e9340d9
Autor:
Roberto Minici, Raffaele Serra, Marco Giurdanella, Marisa Talarico, Maria Anna Siciliano, Gianpaolo Carrafiello, Domenico Laganà
Publikováno v:
Journal of Personalized Medicine, Vol 13, Iss 4, p 640 (2023)
Background: The distal radial artery has emerged as an alternative vascular-access site to conventional transfemoral and transradial approaches. The main advantage over the conventional transradial route is the reduced risk of radial artery occlusion
Externí odkaz:
https://doaj.org/article/bbb42e4fb6974a33b5b7339923d1e641
Autor:
Maria d’Apolito, Rocco Spagnuolo, Maria Anna Siciliano, Vito Barbieri, Cristina Cosco, Lucia Fiorillo, Onofrio Cuomo, Valeria Zuccalà, Pierpaolo Correale, Licia Pensabene, Marco Rossi, Patrizia Doldo, Pierfrancesco Tassone, Pierosandro Tagliaferri
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Immune checkpoint inhibitors (ICIs) represent an important advance in the adjuvant treatment of patients with high-risk melanoma. Although the safety profile of anti-programmed cell death protein-1 (PD-1) is fairly acceptable, different immune-relate
Externí odkaz:
https://doaj.org/article/3140e4e3d7bb48529700ea1b69df5dc3
Autor:
Roberto Minici, Maria Anna Siciliano, Michele Ammendola, Rita Carlotta Santoro, Vito Barbieri, Girolamo Ranieri, Domenico Laganà
Publikováno v:
Cancers, Vol 15, Iss 1, p 257 (2022)
TACE plays a pivotal role in hepatocellular carcinoma, from disease control to downstaging and bridging to liver transplant. Response to TACE is a surrogate marker of tumor aggressive biology, with manifold practical implications such as survival, th
Externí odkaz:
https://doaj.org/article/bea31edccf7b485984511a3aa4e11cd7
Autor:
Roberto Minici, Michele Ammendola, Francesco Manti, Maria Anna Siciliano, Marco Minici, Iman Komaei, Giuseppe Currò, Domenico Laganà
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
According to the EASL Guidelines for the management of hepatocellular carcinoma, transcatheter arterial chemoembolization is the first-line treatment recommended for intermediate-stage HCC. Furthermore, it is widely accepted that patients beyond the
Externí odkaz:
https://doaj.org/article/0ded2adf2511493f9e2f26ce50bf56da
Autor:
Roberto Minici, Michele Ammendola, Francesco Manti, Maria Anna Siciliano, Enrica Giglio, Marco Minici, Marica Melina, Giuseppe Currò, Domenico Laganà
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
In patients with early-stage hepatocellular carcinoma, awaiting liver transplantation, current guidelines by AASLD and ESMO recommend a bridging therapy with a loco-regional treatment to prevent progression outside transplantation criteria. The stand
Externí odkaz:
https://doaj.org/article/ba3d54e35bfc498a8cc02b54a41e27de
Autor:
Maria Cucè, Maria Eugenia Gallo Cantafio, Maria Anna Siciliano, Caterina Riillo, Daniele Caracciolo, Francesca Scionti, Nicoletta Staropoli, Valeria Zuccalà, Lorenza Maltese, Anna Di Vito, Katia Grillone, Vito Barbieri, Mariamena Arbitrio, Maria Teresa Di Martino, Marco Rossi, Nicola Amodio, Pierosandro Tagliaferri, Pierfrancesco Tassone, Cirino Botta
Publikováno v:
Journal of Hematology & Oncology, Vol 12, Iss 1, Pp 1-17 (2019)
Abstract Background Genomic instability is a feature of multiple myeloma (MM), and impairment in DNA damaging response (DDR) has an established role in disease pathobiology. Indeed, a deregulation of DNA repair pathways may contribute to genomic inst
Externí odkaz:
https://doaj.org/article/11a091bda6ff40909d3e7d4d6a5cad95
Autor:
Caterina Riillo, Daniele Caracciolo, Katia Grillone, Nicoletta Polerà, Franca Maria Tuccillo, Patrizia Bonelli, Giada Juli, Serena Ascrizzi, Francesca Scionti, Mariamena Arbitrio, Mariangela Lopreiato, Maria Anna Siciliano, Simona Sestito, Gabriella Talarico, Eulalia Galea, Maria Concetta Galati, Licia Pensabene, Giovanni Loprete, Marco Rossi, Andrea Ballerini, Massimo Gentile, Domenico Britti, Maria Teresa Di Martino, Pierosandro Tagliaferri, Pierfrancesco Tassone
Publikováno v:
Cancers, Vol 14, Iss 12, p 2886 (2022)
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy burdened by poor prognosis. While huge progress of immunotherapy has recently improved the outcome of B-cell malignancies, the lack of tumor-restricted T-cell antigens still hamp
Externí odkaz:
https://doaj.org/article/aa897d1bbceb47cba6a4bc9dd7419bd2
Autor:
Maria Anna Siciliano, Stefano Dastoli, Maria d’Apolito, Nicoletta Staropoli, Pierfrancesco Tassone, Pierosandro Tagliaferri, Vito Barbieri
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundImmune checkpoint inhibitors targeting cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), programmed death-1 receptor (PD-1), and programmed death-1 receptor and its ligand (PD-L1) increased the survival of patients affected by metastati
Externí odkaz:
https://doaj.org/article/216db4de38b847c49f998a124fc7b261
Autor:
Giulio Caridà, Giulia Pelaia, Domenico Ciliberto, Nicoletta Staropoli, Maria Anna Siciliano, Natale Daniele Calandruccio, Daniele Caracciolo, Caterina Riillo, Rosa Toscano, Pierosandro Tagliaferri, Pierfrancesco Tassone, Marco Rossi
Background. Chronic Lymphocytic Leukemia (CLL) is the most common adult leukemia. IgVh unmutated CLL without 17p del/p53 aberrations (UN-only CLL) still carry a poorer prognosis as compared to IgVh mutated (MU-only) cases. The best front line and seq
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::320cf8b34895ac3538e1146af4eff361
https://doi.org/10.21203/rs.3.rs-1494779/v1
https://doi.org/10.21203/rs.3.rs-1494779/v1